GlobeNewswire

Before and after images of a single patient with end-stage metastatic prostate cancer treated with Actinium-225.

Image credit: Clemens Kratochwil et al. J Nucl Med 2016;57:1941-1944

Before and after images of a single patient with end-stage metastatic prostate cancer treated with Actinium-225. The first image (A) was taken before treatment, the second (B) after three doses of Actinium-225, and the third (C) after an additional dose. The patient was treated at the University Hospital Heidelberg.
Image credit: Clemens Kratochwil et al. J Nucl Med 2016;57:1941-1944
Format

JPEG

Source

Canadian Nuclear Laboratories (CNL)

Downloads